Cerus Corp

General ticker "CERS" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $326.0M

Cerus Corp follows the US Stock Market performance with the rate: 2.8%.

Estimated limits based on current volatility of 2.6%: low 1.53$, high 1.62$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.67$, 3.64$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.32$, 4.66$]

Financial Metrics affecting the CERS estimates:

  • Negative: Non-GAAP EPS, $ of -0.20 <= 0.10
  • Negative: Operating profit margin, % of -13.86 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -11.36 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85

Similar symbols

Short-term CERS quotes

Long-term CERS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $159.52MM $188.31MM $186.80MM
Operating Expenses $208.45MM $222.40MM $216.85MM
Operating Income $-48.94MM $-34.08MM $-30.05MM
Non-Operating Income $-5.12MM $-8.26MM $-7.27MM
Interest Expense $4.92MM $5.83MM $8.39MM
R&D Expense $63.69MM $64.11MM $67.64MM
Income(Loss) $-54.06MM $-42.34MM $-37.32MM
Taxes $0.32MM $0.49MM $0.33MM
Profit(Loss) $-54.38MM $-42.83MM $-37.65MM
Stockholders Equity $84.62MM $67.61MM $52.65MM
Inventory $26.79MM $29.00MM $39.87MM
Assets $237.50MM $218.09MM $197.75MM
Operating Cash Flow $-33.92MM $-25.61MM $-43.17MM
Capital expenditure $0.91MM $2.00MM $4.60MM
Investing Cash Flow $12.69MM $8.46MM $8.62MM
Financing Cash Flow $34.29MM $4.19MM $10.67MM
Earnings Per Share* $-0.32 $-0.24 $-0.21

* EPS are Split Adjusted, recent splits may be reflected with a delay.